AlphaYouRT
Insider selling
Rahsaan Thompson sold $438K of Zevra Therapeutics, Inc. (ZVRA) stock
Rahsaan Thompson, Chief Legal & Compliance of Zevra Therapeutics, Inc. (ZVRA), sold 34,557 shares of ZVRA stock worth $438K, per an SEC Form 4 filed Jun 23, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Jun 21, 2026, 2 days before it was made public.
ZVRA has moved -9.5% since the trade date, from $12.90 to $11.67 (Sep 21, 2026 close).
- Traded
- Jun 21, 2026
- Disclosed
- Jun 23, 2026
- Filing delay
- 2 days
- Price since
- -9.5%
- Role
- Chief Legal & Compliance
- Source
- SEC Form 4
More ZVRA insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.